Envista (NYSE:NVST) Issues FY 2025 Earnings Guidance

Envista (NYSE:NVST) updated its FY 2025 earnings guidance on Wednesday. The company provided EPS guidance of 0.950-1.050 for the period, compared to the consensus EPS estimate of 1.120. The company issued revenue guidance of -.

Envista Price Performance

Shares of Envista stock traded up $1.10 during mid-day trading on Thursday, reaching $21.67. 3,267,858 shares of the stock were exchanged, compared to its average volume of 2,119,679. The company has a current ratio of 2.08, a quick ratio of 1.77 and a debt-to-equity ratio of 0.42. The company has a market cap of $3.73 billion, a price-to-earnings ratio of -2.77, a price-to-earnings-growth ratio of 1.82 and a beta of 1.34. Envista has a fifty-two week low of $15.15 and a fifty-two week high of $24.79. The firm has a 50-day simple moving average of $19.97 and a 200 day simple moving average of $19.10.

Envista (NYSE:NVST) last issued its quarterly earnings data on Wednesday, February 5th. The company reported $0.24 EPS for the quarter, topping analysts’ consensus estimates of $0.23 by $0.01. Envista had a negative net margin of 53.42% and a positive return on equity of 3.76%. On average, sell-side analysts predict that Envista will post 0.72 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

NVST has been the topic of a number of recent analyst reports. Piper Sandler raised their target price on Envista from $17.00 to $18.00 and gave the stock a “neutral” rating in a report on Monday. Jefferies Financial Group lifted their price target on shares of Envista from $20.00 to $22.00 and gave the stock a “hold” rating in a research report on Thursday, January 23rd. Stifel Nicolaus lifted their target price on Envista from $18.00 to $21.00 and gave the stock a “buy” rating in a report on Wednesday, October 23rd. Needham & Company LLC reaffirmed a “hold” rating on shares of Envista in a research report on Thursday. Finally, Wells Fargo & Company boosted their price objective on Envista from $20.00 to $21.00 and gave the company an “equal weight” rating in a research report on Thursday. Two research analysts have rated the stock with a sell rating, ten have assigned a hold rating and three have issued a buy rating to the company’s stock. According to MarketBeat, Envista currently has a consensus rating of “Hold” and a consensus target price of $20.21.

Envista Company Profile

Envista Holdings Corporation, together with its subsidiaries, develops, manufactures, markets, and sells dental products in the United States, China, and internationally. The company operates in two segments, Specialty Products & Technologies, and Equipment & Consumables. The Specialty Products & Technologies segment offers dental implant systems, guided surgery systems, biomaterials, and prefabricated and custom-built prosthetics to oral surgeons, prosthodontists and periodontists, and general dentist; and brackets and wires, tubes and bands, archwires, clear aligners, digital orthodontic treatments, retainers, and other orthodontic laboratory products.